Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash from Investing Activities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Cash from Investing Activities for 9 consecutive years, with -$28000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$28000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$51000.0, a 40.0% increase, with the full-year FY2024 number at -$67000.0, down 9.84% from a year prior.
  • Cash from Investing Activities was -$28000.0 for Q3 2025 at Catheter Precision, down from -$13000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $3.3 million in Q3 2021 to a low of -$45000.0 in Q2 2024.
  • A 5-year average of $260285.7 and a median of -$11500.0 in 2025 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 14643.48% in 2021, then crashed 185.71% in 2023.
  • Catheter Precision's Cash from Investing Activities stood at -$1000.0 in 2021, then skyrocketed by 2200.0% to $21000.0 in 2022, then plummeted by 185.71% to -$18000.0 in 2023, then tumbled by 150.0% to -$45000.0 in 2024, then skyrocketed by 37.78% to -$28000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Cash from Investing Activities are -$28000.0 (Q3 2025), -$13000.0 (Q2 2025), and -$10000.0 (Q1 2025).